Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001564590-22-038379
Filing Date
2022-11-28
Accepted
2022-11-28 06:03:21
Documents
88
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 6-K meso-6k_20220930.htm   iXBRL 6-K 4624724
  Complete submission text file 0001564590-22-038379.txt   18663569

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA meso-20220930.xsd EX-101.SCH 113547
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE meso-20220930_cal.xml EX-101.CAL 89761
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE meso-20220930_def.xml EX-101.DEF 287893
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE meso-20220930_lab.xml EX-101.LAB 609729
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE meso-20220930_pre.xml EX-101.PRE 488515
82 EXTRACTED XBRL INSTANCE DOCUMENT meso-6k_20220930_htm.xml XML 5194154
Mailing Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000
Business Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000 613 9639 6036
MESOBLAST LTD (Filer) CIK: 0001345099 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-37626 | Film No.: 221421040
SIC: 2836 Biological Products, (No Diagnostic Substances)